Cosenza, 21 APR - The Higher Institute of Health has approved the clinical trial phase of a therapeutic vaccine against AIDS. The announcement was made today prof. Arnaldo Caruso, who discovered the vaccine and the scientific director of human experimentation Medestea designated by the company during a demonstration in the Thirties, in the province of Cosenza. "The vaccine - says Caruso - is based on the peptide AT20 matrix protein p17 of HIV." Caruso, a native of the small town of Cosenza Presila, is a professor of microbiology at the medical school in Brescia. "The first injection - he said - is scheduled for June and will be performed on a patient in Perugia. The choice of the Umbrian city is not random because it demonstrates the commitment to the search for the Fondazione Cassa di Risparmio of the city, and the presence, in Perugia, the leader of the clinical trial, prof. Franco Baldelli. The drug and the entire dossier has been developed by clinical Medestea of \u200b\u200bTurin, which is also involved in the implementation of human experimentation. "Thirty-six - said Caruso - patients who will undergo the testing in Italy. They will be followed in the centers of infectious diseases in Brescia, Milan and Turin. The experiment consists of five doses of the drug after one month each other and further follow up of six months. The entire phase one should be finished by the end of 2011. "(Reuters)
(watch the service)
0 comments:
Post a Comment